St. Jude Recall May Cost Patients
Patients could face thousands of dollars of out-of-pocket expenses to replace a recalled heart-device from St. Jude Medical. Read more…
August 26th, 2012
Posted in
Drug
Top Medical Searches
- Abilify
- Abortion
- Accupril
- Accutane
- Aceon
- Aciphex
- Acne
- Actonel
- Actos
- Acupuncture
- Acyclovir
- Adalat
- Adderall
- ADHD
- Adipex
- Advair
- Albuterol
- Alcoholism
- Alesse
- Aleve
- Alimta
- Allegra
- Allergy
- Alli
- Allopurinol
- Alphagan
- Alprazolam
- Altace
- Alzheimers
- Amaryl
- Ambien
- Ambrotose
- Amitriptyline
- Amoxicillin
- Amoxil
- Amphetamine
- Amyl Nitrite
- Anabolic Steroid
- Angina
- Anxiety
- Arava
- Aricept
- Arimidex
- Aromatherapy
- Arthritis
- Asacol
- Asthma
- Atenolol
- Ativan
- Atrovent
- Augmentin
- Avandamet
- Avandia
- Avapro
- Avodart
- Ayurveda
- Azmacort
- Bacterial Infections
- Bactobran
- Bactrim
- Baycol
- Bextra
- Biaxin
- Bipolar disorder
- Bontril
- Botox
- Breast cancer
- Bulimia
- Buspar
- Cancer & Oncology
- Cardizem
- Cardura
- Carisoprodol
- Ceftin
- Cefzil
- Celebrex
- Celexa
- Cephalexin
- Chantrix
- Cholesterol
- Cialis
- Cipro
- Ciprofloxacin
- Citalopram
- Claritin
- Climara
- Clonazepam
- Clonidine
- Clozaril
- Cocaine
- Colds & Flu
- Colon cancer
- Combivent
- Constipation
- COPD
- Coumadin
- Cozaar
- Crestor
- Crohns disease
- Cyclobenzaprine
- Cymbalta
- Depakote
- Depression
- Dermatitis
- Detrol
- Diabetes
- Diarrhea
- Diazepam
- Diflucan
- Dilantin
- Diovan
- Doxycycline
- Drug abuse
- Eczema
- Effexor
- Elocon
- Enablex
- Erectile Dysfunction
- Estroven
- Evista
- Femara
- Fioricet
- Flomax
- Flonase
- Flovent
- Folic Acid
- Foradil
- Fosamax
- Fungal Infections
- Furosemide
- Gabapentin
- Gastrointestinal
- Gemfibrozil
- Genital warts
- GERD
- Glucophage
- Glucotrol
- Glyburide
- Gout
- Growth Hormone
- Hair Loss
- Hayfever
- Heart disease
- Hepatitis
- Herceptin
- Herpes
- HIV/AIDS
- Hoodia
- Hyalgan
- Hydrochlorothiazide
- Hydrocodone
- Hypertension
- Hypothyroidism
- Hyzaar
- Ibuprofen
- Imitrex
- Incontinence
- Insomnia
- Insulin
- Irritable bowel
- Isosorbide Mononitrate
- Keppra
- Ketamine
- Ketek
- Kidney stone
- Klonopin
- Lamictal
- Lamisil
- Lanoxin
- Lescol
- Leukemia
- Levaquin
- Levitra
- Levothroid
- Levoxyl
- Lexapro
- Lipitor
- Lisinopril
- Lithium
- Lo Ovral
- Lodine
- Loestrin
- Lorazepam
- Lortab
- Lotensin
- Lotrel
- Lotrisone
- LSD
- Lung cancer
- Macrobid
- Magnetic Therapy
- Marijuana
- Massage Therapy
- MDMA – Ecstacy
- Meditation
- Melanoma
- Melatonin
- Menopause
- Mental Health
- Meridia
- Mescaline
- Metformin
- Methadone
- Methamphetamine
- Methocarbamol
- Methylphenidate
- Methylprednisolone
- Metoprolol
- Metronidazole
- Migraine
- Minoxidil
- Mobic
- Morphine
- Nail fungus
- Naprosyn
- Naproxen
- Nasacort
- Nasonex
- Naturopathy
- Neoral
- Neurontin
- Nexium
- Nicotine
- Norvasc
- Obesity
- Ortho Try-cyclen
- Orthovisc
- Osteoarthritis
- Osteoporosis
- Ovarian cancer
- Oxycodone
- Oxycontin
- Pamabrom
- Pancreatic cancer
- Paxil
- Penicillin
- Pepcid
- Percocet
- Phenergan
- Phentermine
- Plavix
- Pms
- Potassium
- Pravachol
- Prednisone
- Pregnancy
- Premarin
- Prempro
- Prevacid
- Prilosec
- Prinivil
- Procardia
- Promethazine
- Propecia
- Propoxyphene
- Proscar
- Prostate cancer
- Protonix
- Protopic
- Proventil
- Provigil
- Prozac
- Psilocybin
- Psoriasis
- Ranitidine
- Relafen
- Remeron
- Remicade
- Rheumatoid arthritis
- Risperdal
- Ritalin
- Rogaine
- Rohypnol
- Rosacea
- Roxicet
- Rozerem
- Schizophrenia
- Seizures
- Serevent
- Seroquel
- Serzone
- Sexual Health
- Shingles
- Singulair
- Soma
- Spiriva
- Strattera
- Stroke
- Suboxone
- Synthroid
- Synvisc
- Tamiflu
- Tamoxifen
- Temazepam
- Terazosin
- Tiazac
- Tobradex
- Topamax
- Toprol
- Tramadol
- Trasylol
- Traumeel
- Trazodone
- Triamterene
- Trimox
- Triphasil
- Tysabri
- Ultracet
- Ultram
- Urinary Tract Infection
- Vaccines
- Valium
- Valtrex
- Varicose veins
- Vasotec
- Veetids
- Verapamil
- Viagra
- Vicodin
- Vicoprofen
- Vioxx
- Voltaren
- Vytorin
- Warfarin
- Weight loss
- Wellbutrin
- Xalatan
- Xanax
- Xenical
- Xolair
- Yasmin
- Yoga
- Zestoretic
- Zestril
- Zetia
- Ziac
- Zithromax
- Zocor
- Zoloft
- Zomig
- Zyprexa
- Zyrtec
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
-
Recent Posts
- Research Reveals Yeasty Beasts Living On Our Skin
- Oncolytics cancer drug meets mid-stage trial goal, shares rise
- U.S. government taps GlaxoSmithKline for new antibiotics
- What Would Ben Franklin Do With A Bunch Of Balloons? Everything
- COPD May Be Over-Diagnosed Among Uninsured
- When it comes to deadly viruses, what’s in a name?
- Pfizer to spin off Zoetis stake to shareholders
- Swiss billionaires buy Merck Serono HQ for biotech campus
- Quantum Or Not, New Supercomputer Is Certainly Something Else
- Los Angeles voters OK move to curtail medical marijuana outlets
- Immune system cancer drugs tipped to be a $35 billion market
- Removing Tonsils Helps Kids With Sleep Apnea, Study Finds
- This Is Your Kid’s Brain Without Sleep
- COPD Patients May Do Fine With Shorter Course of Steroids
- Storm Chasers Seek Thrills, But Also Chance To Warn Others
- Busy Parents’ Plan for Losing Weight
- Pain a Common Problem for People With COPD
- China’s bird flu outbreak cost $6.5 billion
- Americans Still Making Unhealthy Choices: CDC
- Merck signs $5 billion share buyback agreement with Goldman Sachs
Newsletter